68 related articles for article (PubMed ID: 6190840)
1. Genotoxicity and Mutagenicity of Inosine Pranobex.
Tobólska S; Terpiłowska S; Jaroszewski J; Siwicki AK
J Vet Res; 2018 Jun; 62(2):207-213. PubMed ID: 30364916
[TBL] [Abstract][Full Text] [Related]
2. Partial restoration of impaired interleukin-2 production and Tac antigen (putative interleukin-2 receptor) expression in patients with acquired immune deficiency syndrome by isoprinosine treatment in vitro.
Tsang KY; Fudenberg HH; Galbraith GM; Donnelly RP; Bishop LR; Koopmann WR
J Clin Invest; 1985 May; 75(5):1538-44. PubMed ID: 2581997
[TBL] [Abstract][Full Text] [Related]
3. Inosine pranobex. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.
Campoli-Richards DM; Sorkin EM; Heel RC
Drugs; 1986 Nov; 32(5):383-424. PubMed ID: 2431857
[TBL] [Abstract][Full Text] [Related]
4. Ability of isoprinosine to restore interleukin-2 production and T cell proliferation in autoimmune mice.
Fischbach M; Talal N
Clin Exp Immunol; 1985 Aug; 61(2):242-7. PubMed ID: 2412742
[TBL] [Abstract][Full Text] [Related]
5. Immunopharmacology of the hypoxanthine containing compounds isoprinosine and NPT 15392.
O'Neill BB; Ginsberg T; Hadden J
Prog Clin Biol Res; 1984; 161():525-41. PubMed ID: 6207547
[No Abstract] [Full Text] [Related]
6. Update on anaesthesia and the immune response.
Moudgil GC
Can Anaesth Soc J; 1986 May; 33(3 Pt 2):S54-60. PubMed ID: 2941118
[No Abstract] [Full Text] [Related]
7. Restoration of immune responses of aging hamsters by treatment with isoprinosine.
Tsang KY; Fudenberg HH; Gnagy MJ
J Clin Invest; 1983 Jun; 71(6):1750-5. PubMed ID: 6190840
[TBL] [Abstract][Full Text] [Related]
8. In vitro restoration of immune responses in aging humans by isoprinosine.
Tsang KY; Pan JF; Swanger DL; Fudenberg HH
Int J Immunopharmacol; 1985; 7(2):199-206. PubMed ID: 2409037
[TBL] [Abstract][Full Text] [Related]
9. Isoprinosine as an immunopotentiator in an animal model of human osteosarcoma.
Tsang KY; Fudenberg HH
Int J Immunopharmacol; 1981; 3(4):383-9. PubMed ID: 6174468
[TBL] [Abstract][Full Text] [Related]
10. Modulation of human T lymphocyte functions by isoprinosine.
Rey A; Cupissol D; Thierry C; Esteve C; Serrou B
Int J Immunopharmacol; 1983; 5(1):99-103. PubMed ID: 6188707
[TBL] [Abstract][Full Text] [Related]
11. Preliminary characterization in mice of the effect of isoprinosine on the immune system.
Vecchi A; Sironi M; Spreafico F
Cancer Treat Rep; 1978 Nov; 62(11):1975-9. PubMed ID: 83191
[TBL] [Abstract][Full Text] [Related]
12. Isoprinosine restores in vitro T lymphocyte functions of cyclophosphamide immunosuppressed mice.
Barasoain I; Rejas MT; Portoles MP; Ojeda G; Rojo JM
Int J Immunopharmacol; 1987; 9(4):489-96. PubMed ID: 2442109
[TBL] [Abstract][Full Text] [Related]
13. IMMUNOLOGICAL DEFECT IN AGED POPULATION AND ITS RELATIONSHIP TO CANCER.
GROSS L
Cancer; 1965 Feb; 18():201-4. PubMed ID: 14254076
[No Abstract] [Full Text] [Related]
14. Antibody production and development of contact skin sensitivity in guinea pigs of various ages.
BAER H; BOWSER RT
Science; 1963 Jun; 140(3572):1211-2. PubMed ID: 13966058
[TBL] [Abstract][Full Text] [Related]
15. Age changes in blood of the golden hamster.
HOUSE EL; PANSKY B; JACOBS MS
Am J Physiol; 1961 May; 200():1018-22. PubMed ID: 13716162
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
